Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-4382

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-4382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5811124d Bd64 4339 Ba4b Fa9026a251b7 00

Pantoprazole Sodium delayed-release tablets, USP 40 mg label panel listing contents as 10 tablets. Provides drug strength, dosage form, quantity, manufacturer Mylan Pharmaceuticals Inc., and distributor Cardinal Health. Includes storage instructions, dosage warnings, and imprint description of tablets.*

FDA Label Image

Pantoprazole Structural Formula (8f0bbcb2 8643 41a9 B9fd A5f25a7dba5d 01)

Chemical structure of pantoprazole sodium, the active ingredient in Pantoprazole Sodium 40 mg delayed-release tablets by Cardinal Health 107, LLC. The diagram shows the molecular arrangement including sodium ion, fluorine atoms, methoxy groups, and other chemical bonds relevant to the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.